Co-morbidity in the ageing haemophilia patient: The down side of increased life expectancy

Research output: Contribution to journalReview articlepeer-review

43 Citations (Scopus)

Abstract

Because of an increased life expectancy, (age-related) co-morbidity is becoming a common occurrence in haemophilia patients. In this review, haemophilia-related and non-haemophilia-related medical problems, treatment recommendations and psychosocial consequences in ageing haemophilia patients are discussed. Haemophilic arthropathy is an important cause of pain and disability, and a frequent indication for surgery in haemophilia patients. In addition, many adult patients are infected with hepatitis C or HIV, the consequences and treatment of which can add to physical and mental discomfort. Moreover, inhibitors against factor VIII can also develop in adulthood, especially in patients with mild haemophilia. Hypertension is reported to occur more often in haemophilia patients than in the general population. Other internal problems, like renal abnormalities, overweight, diabetes mellitus and hypercholesterolemia are discussed. Haemophilia seems to protect against cardiovascular disease, although the incidence is increasing. Recommendations are given on dealing with tooth extractions, surgical interventions and sexuality problems in patients with haemophilia. In addition to haemophilia in itself, co-morbidity has a major psychological impact, and an important effect on quality of life. It can also result in complex treatment regimens, in which coordination between health care workers is essential.

Original languageEnglish
Pages (from-to)853-863
Number of pages11
JournalHaemophilia
Volume15
Issue number4
DOIs
Publication statusPublished - 10 Jul 2009

Keywords

  • Ageing
  • Co-morbidity
  • Haemophilia

Fingerprint

Dive into the research topics of 'Co-morbidity in the ageing haemophilia patient: The down side of increased life expectancy'. Together they form a unique fingerprint.

Cite this